Heart failure and comorbidities: renal failure, diabetes, atrial fibrillation, and inflammation

Yes, hyperglycaemia is indeed a modifiable cardiac risk factor: so says Mendel

(2015) D. L. Bhatt   EUROPEAN HEART JOURNAL

Sleep apnoea in acute heart failure: fluid in flux

(2015) J. S. Floras et al.   EUROPEAN HEART JOURNAL

Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation†

(2015) Michelle L. O'Donoghue et al.   EUROPEAN HEART JOURNAL

Should patients on vitamin K antagonists be treated differently?

(2015) S. D. Pokorney et al.   EUROPEAN HEART JOURNAL

The research venture in arrhythmogenic right ventricular cardiomyopathy: a paradigm of translational medicine

(2015) G. Thiene   EUROPEAN HEART JOURNAL

The kidney in heart failure: an update

(2015) Kevin Damman et al.   EUROPEAN HEART JOURNAL

Presentation blood glucose and death, hospitalization, and future diabetes risk in patients with acute heart failure syndromes

(2015) Maneesh Sud et al.   EUROPEAN HEART JOURNAL

Exercise and the heart: the good, the bad, and the ugly

(2015) S. Sharma et al.   EUROPEAN HEART JOURNAL

Sudden cardiac death in the young: the molecular autopsy and a practical approach to surviving relatives

(2015) C. Semsarian et al.   EUROPEAN HEART JOURNAL

Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery disease

(2015) Stephanie Ross et al.   EUROPEAN HEART JOURNAL

Sleep disordered breathing and post-discharge mortality in patients with acute heart failure

(2015) R. Khayat et al.   EUROPEAN HEART JOURNAL

Endurance sports precipitate phenotypic expression of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) in asymptomatic PKP2-mutation carriers

(2014) J.- L. Pasquie et al.   EUROPEAN HEART JOURNAL

Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial

(2014) B. A. Steinberg et al.   EUROPEAN HEART JOURNAL

Nano-scale treatment for a macro-scale disease: nanoparticle-delivered siRNA silences CCR2 and treats myocarditis

(2014) L. T. Cooper et al.   EUROPEAN HEART JOURNAL

Prognosis and treatment of atrial fibrillation patients by European cardiologists: One Year Follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry)

(2014) Gregory Y.H. Lip et al.   EUROPEAN HEART JOURNAL

Silencing of CCR2 in myocarditis

(2014) Florian Leuschner et al.   EUROPEAN HEART JOURNAL

Clinical significance of electrocardiographic right ventricular hypertrophy in athletes: comparison with arrhythmogenic right ventricular cardiomyopathy and pulmonary hypertension

(2013) Abbas Zaidi et al.   EUROPEAN HEART JOURNAL

Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

(2013) A. L. P. Caforio et al.   EUROPEAN HEART JOURNAL

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II

(2013) Joshua A. Beckman et al.   EUROPEAN HEART JOURNAL

Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis

(2013) K. Damman et al.   EUROPEAN HEART JOURNAL

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I

(2013) Francesco Paneni et al.   EUROPEAN HEART JOURNAL

Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial

(2011) J. E. A. Blair et al.   EUROPEAN HEART JOURNAL